Cordula Fassbender

Title: Cordula Fassbender: Innovator in Cancer Therapeutics

Introduction

Cordula Fassbender is a prominent inventor based in Cologne, Germany. She has made significant contributions to the field of cancer research, particularly in developing therapeutic agents that target cancer cells. Her innovative work focuses on characterizing cancer cells with individual properties, which is crucial for personalized medicine.

Latest Patents

Fassbender holds a patent for a therapeutic, prophylactic, and diagnostic agent for cancer. This agent is designed to damage the membrane and kill cancer cells, especially those in the blood-forming system. The patent details a formulation that includes membrane protein aggregates containing core histones or their parts. The therapeutic agent comprises at least one pure histone or its active sequence section, selected from a group that includes histone H1, H2A, H2B, H3, and H4, among others. This innovative approach aims to improve cancer treatment outcomes.

Career Highlights

Throughout her career, Cordula Fassbender has demonstrated a commitment to advancing cancer therapeutics. Her research has led to the development of novel agents that have the potential to transform cancer treatment. With her expertise, she has positioned herself as a key figure in the field of oncology.

Collaborations

Fassbender has collaborated with notable colleagues, including Michael Zeppezauer and Hans-Peter Leinenbach. These partnerships have enhanced her research efforts and contributed to the advancement of cancer therapies.

Conclusion

Cordula Fassbender's innovative work in cancer therapeutics highlights her dedication to improving treatment options for patients. Her patent represents a significant step forward in the fight against cancer, showcasing her role as a leading inventor in this critical field.